Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
The legal ecology of resistance, or why normal IP rules should not apply to antibiotics- An IP seminar at the University of Oxford
Minssen, Timo (Speaker)
25 Apr 2014Activity: Talk or presentation types › Lecture and oral contribution
The legal dimensions of Big Data: University of Copenhagen
Minssen, Timo (Lecturer)
20 May 2016Activity: Talk or presentation types › Lecture and oral contribution
The legal dimension of large European Research Infrastructures and the CoNext project
Minssen, Timo (Speaker)
31 Oct 2014Activity: Talk or presentation types › Lecture and oral contribution
The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?
Minssen, Timo (Lecturer)
12 Aug 2013Activity: Talk or presentation types › Lecture and oral contribution
The US Supreme Court in FTC v. Actavis - Context, outcome & implications
Minssen, Timo (Lecturer)
18 Jun 2013Activity: Talk or presentation types › Lecture and oral contribution
The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.
Minssen, Timo (Lecturer)
7 Oct 2014Activity: Talk or presentation types › Lecture and oral contribution
The Scope of Protection for Biotech-Patents after Monsanto v. Cefetra
Minssen, Timo (Speaker)
8 Nov 2011Activity: Talk or presentation types › Lecture and oral contribution
The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)
Minssen, Timo (Invited speaker)
8 Feb 2019Activity: Talk or presentation types › Lecture and oral contribution
The Path to Legalized Medical Assistance in Dying in Canada and the Role of Evidence
Minssen, Timo (Organizer)
8 Feb 2018Activity: Participating in an event - types › Organisation of and participation in conference
The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe
Minssen, Timo (Speaker)
13 Sep 2011Activity: Talk or presentation types › Lecture and oral contribution
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2193
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published